FAST NEWS: Clover to Complete Covid Vaccine Applications by Year-End
The latest: Clover Biopharmaceuticals Ltd. (2197.HK) said on Sunday it plans to complete registration applications for its lead Covid-19 vaccine candidate, SCB-2019, with the China National Medical Products Administration, the…
RELATED ARTICLES
-
With healthier finances, Clover Bio shifts to flu and RSV vaccines
2197.HK
- Health Guard plans dual listing to fund HPV vaccine fight
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
-
FAST NEWS: Clover Bio slumps after booting from China-Hong Kong Stock Connect
2197.HK
- China’s mRNA pioneer Stemirna faces post-Covid reinvention test
-
FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine
6185.HK 688185.SHG
-
Missing the Covid boat, Junshi stumbles back to old business
1877.HK 688180.SHG
Discover hidden China stock gems in our weekly newsletter